Visalytics
Visalytics
dismissed EB-2 (NIW) RFE Issued

Pharmaceutical Chemist

Health Industry · 2024-05-02

Decision Date
2024-05-02
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to develop a pharmacotherapeutic follow-up program for women aged 40 to 60 post-COVID-19 vaccination. The project involves using a WhatsApp application to monitor symptoms for 15 days to prevent and detect blood clots and direct patients to medical centers. The goal is to improve women's health and the U.S. healthcare system through pharmacovigilance and data sharing.

Framework Evaluation

0 of 3 criteria met
1 Substantial Merit and National Importance Not Met

The endeavor has substantial merit but lacks national importance due to insufficient evidence of prospective impact on the field or economy.

Why This Petition Was Denied

The appeal was dismissed because the petitioner failed to establish the national importance of the endeavor (Prong 1). The record lacked evidence of a scalable logistics plan, funding, or previous experience with similar studies, and did not demonstrate substantial positive economic effects or broader industry impact.

Request for Evidence (RFE)

Unsuccessfully Addressed

The RFE addressed the petitioner's EB-2 qualification and the national interest waiver criteria. The petitioner responded with additional statements regarding her experience and the social welfare benefits of her work.

RFE Targets
Substantial Merit and National Importance

Evidence

Evidence Types
Media Coverage
Reference Letters Dependent
Government Alignment

Similar Cases

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Illinois 110 days 2023-02-02
The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.
View Case

Others

Healthcare · Ethiopia

USCIS EB-2 (NIW) dismissed
Ethiopia 2023-10-11
The petitioner proposes to work in the United States with hospitals or laboratory corporations to provide quality assurance and improvement in health systems and laboratory services. The work includes management of laboratory information systems, accreditation, data digitalization, and technical proficiency in molecular laboratory, hematology, and clinical chemistry.

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Pharmaceuticals cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-05-02.

Browse all cases

At a Glance

Outcome dismissed
RFE Issued
Criteria Met 0 / 3
Evidence Types 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist